Telomir Pharmaceuticals, Inc. financial data

Symbol
TELO on Nasdaq
Location
Miami, FL
Fiscal year end
31 December
Latest financial report
17 Mar 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 563% % 63%
Debt-to-equity 22% % -46%
Return On Equity -315% % 73%
Return On Assets -259% % 69%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 34,380,971 shares 16%
Common Stock, Shares, Outstanding 34,380,971 shares 16%
Entity Public Float $18,100,000 USD -84%
Weighted Average Number of Shares Outstanding, Basic 31,653,094 shares 7.2%
Weighted Average Number of Shares Outstanding, Diluted 31,653,094 shares 7.2%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $2,435,569 USD 9%
General and Administrative Expense $8,103,280 USD -16%
Operating Income (Loss) $2,187,872 USD 14%
Nonoperating Income (Expense) $15,445 USD
Net Income (Loss) Attributable to Parent $10,413,205 USD 37%
Earnings Per Share, Basic -0.33 USD/shares 41%
Earnings Per Share, Diluted -0.33 USD/shares 41%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $754,323 USD
Assets, Current $7,341,361 USD 454%
Assets $7,341,361 USD 454%
Liabilities, Current $1,427,991 USD 110%
Liabilities $1,427,991 USD 110%
Retained Earnings (Accumulated Deficit) $41,010,063 USD -34%
Stockholders' Equity Attributable to Parent $5,913,370 USD 820%
Liabilities and Equity $7,341,361 USD 454%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $863,132 USD 55%
Common Stock, Shares Authorized 300,000,000 shares 0%
Common Stock, Shares, Issued 34,380,971 shares 16%
Common Stock, Par or Stated Value Per Share 0 USD/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $863,132 USD -126%
Deferred Tax Assets, Valuation Allowance $11,274,876 USD 57%
Deferred Tax Assets, Gross $11,274,876 USD 57%
Deferred Tax Assets, Operating Loss Carryforwards $7,643,465 USD 73%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 100,000,000 shares 0%
Additional Paid in Capital $46,923,433 USD 50%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense $1,400,000 USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares